Rx drug information, pharmaceutical research, clinical trials, news, and more
URSO 250 is a bile acid available as 250 mg film-coated tablets for oral administration.
URSO 250 (ursodiol) tablets are indicated for the treatment of patients with primary biliary cirrhosis.
Primary Biliary Cirrhosis Source: MedicineNet ursodiol Specialty [2005.09.17]
Clinical Trial: Randomized controlled trial of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol. [2008.07.09]
Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition. [2008.02]
Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. [2007.06.27]
Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. [2007.06]
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. [2006.12]
Trial of High-Dose Urso in Primary Sclerosing Cholangitis [Completed]
Ursodiol in Huntington's Disease [Recruiting]
Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients [Completed]
Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C [Completed]
Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis [Recruiting]
-- advertisement --
All Rights reserved - Copyright DrugLib.com, 2006-2008